Patch pump versus conventional pump: Postprandial glycemic excursions and the influence of wear time

Diabetes Technology and Therapeutics

Volumn 15, Issue 7, 2013, Pages 575-579

  Luijf, Yoeri M ^a   Arnolds, Sabine ^b   Avogaro, Angelo ^c   Benesch, Carsten ^b   Bruttomesso, Daniela ^c   Farret, Anne ^d   Heinemann, Lutz ^b   Place, Jerome ^d   Renard, Eric ^d   Scotton, Rachele ^c   Devries, J Hans ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Profil Institut fur Stoffwechselforschung GmbH   (Germany)

^c UNIVERSITY OF PADOVA   (Italy)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEMS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN INFUSION SYSTEMS; INSULIN LISPRO; MATERIALS TESTING; POSTPRANDIAL PERIOD; SKIN ABSORPTION; TRANSDERMAL PATCH;

EID: 84880307191     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0016     Document Type: Article

References (10)

1. Schaepelynck P, Darmon P, Molines L, Jannot-Lamotte MF, Treglia C, Raccah D: Advances in pump technology: Insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. Diabetes Metab 2011;37(Suppl 4):S85-S93
2. Zisser HC: The OmniPod Insulin Management System: The latest innovation in insulin pump therapy. Diabetes Ther 2010;1:10-24
3. Anhalt H, Bohannon NJ: Insulin patch pumps: Their development and future in closed-loop systems. Diabetes Technol Ther 2010;12(Suppl 1):S51-S58
4. Heinemann L, Krinelke L: Insulin infusion set: The achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol 2012;6:954-964
5. Clausen TS, Kaastrup P, Stallknecht B: Effect of insulin catheter wear-Time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther 2009;11:575-580
6. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA: Effect of age of infusion site and type of rapid-Acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009;32:240-244
7. Schmid V, Hohberg C, Borchert M, Forst T, Pfützner A: Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy -Trouble starts on day 3. J Diabetes Sci Technol 2010;4:976-982
8. Muchmore DB, Vaughn DE: Accelerating and improving the consistency of rapid-Acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase. J Diabetes Sci Technol 2012;6:764-772
9. Heinemann L, Benesch C, Devries JH: AP@home: A novel European approach to bring the artificial pancreas home. J Diabetes Sci Technol 2011;5:1363-1372
10. Lindpointner S, Korsatko S, Kohler G, Kohler H, Schaller R, Kaidar R, Yodfat O, Schaupp L, Ellmerer M, Pieber TR, Regittnig W: Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes. Diabetes Care 2010;33:595-601